SBRA | Sabra Healthcare REITNASDAQReal EstateCommon stock golden cross and death cross projections, cross tests and history

$20.35
+$0.63 (+3.19%)

Sabra Healthcare REIT (SBRA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

Right now the daily is the chart to watch. SBRA printed a death cross in Oct 2026, and price has already pulled back to the 50 inside the seven-bar window, so the cross test is open. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $19.74 vs 50 $19.82 / 200 $16.48
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 26 Aug 2024 ยท projected 17 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $20.35 vs 50 $19.33 / 200 $20.02
Projection
No cross projected
Test
No active test
Last cross
Death cross 6 Oct 2026 ยท projected 28 bars out

Cross history

25
crosses on record since 2017
12 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Oct 2026Death moderatedaily17 bars outActive Cross Test
6 Oct 2026Death4-hour28 bars outNot tested
27 Jul 2026Golden4-hour24 bars outNot tested
11 Jun 2026Death4-hour27 bars outNot tested
2 Dec 2025Golden4-hour26 bars outNot tested

About SBRA

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$41.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorReal Estate
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.